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Abstract
Introduction
Cardiac surgery with the use of cardiopulmonary bypass is known to induce distinct meta-
bolic changes. Respective changes in acid-base status including increased systemic lactate
levels were previously related to clinical outcomes, but data remain controversial. Therefore,
we aim to investigate the relevance of lactate and base excess (BE) levels on ICU-mortality
in patients admitted to the ICU after cardiac surgery.
Materials and methods
Perioperative data of patients treated in a tertiary care academic center admitted to the ICU
after on-pump surgery were analyzed in a retrospective fashion. Receiver operation charac-
teristic (ROC) curves were constructed for admission lactate-levels and BE with calculation
of optimal cut-off values to predict ICU mortality. Univariate followed by multivariate regres-
sion models were constructed to identify potential outcome-relevant indices.
Results
Data from 1,058 patients were included in the analysis. Area under the curves for prediction
of ICU mortality were 0.79 for lactate levels at ICU admission (sensitivity 61.9%/ specificity
87.5%; optimal cut-off level 3.9mmol/l), and 0.7 for BE (sensitivity 52.4%/ specificity 93.8%,
optimal cut-off level -6.7), respectively. Multivariate regression identified BE < -6.7 as the
single metabolic predictor of ICU-mortality (HR 4.78, 95%-CI 1.4–16.33, p = 0.01). Explor-
ative subgroup analyses revealed that the combination of lactate3.9mmol/l and BE -6.7
has stronger impact on mortality than a combination of lactate of >3.9mmol/l and BE > -6.7
(HR 2.56, 95%-CI 0.18–37.17).
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Conclusions
At ICU-admission, severely reduced BE appears superior to hyperlactatemia with regard to
prediction of ICU-mortality in patients after cardiac surgery.
Introduction
Cardiac surgery with use of cardiopulmonary bypass (CPB) is known to induce distinct post-
operative metabolic changes, which have a major influence on physiological processes [1]. The
underlying causes for respective acid-base disturbances after cardiac surgery are manifold and
may best be reflected by changes in lactate-levels and base excess (BE).
Elevated lactate levels after cardiac surgery may be caused by anaerobic glycolysis due to tis-
sue hypoxia (known as hyperlactatemia “type A”) related to insufficient macro- or micro-
hemodynamics, by pulmonary diseases or by decreased oxygen carrying capacity related to
bleeding [2–5]. Likewise, increased lactate levels from non-hypoxic origins are known as “type
b”-hyperlactatemia, may occur in cardiosurgical patients [6]. Furthermore, drug therapy [6–
8], hypothermia and the usage of CPB [3, 9] may lead to elevated lactate levels post cardiac sur-
gery. Similar like lactate levels, an elevated base deficiency (BD) has many causes post-cardiac
surgery [10–12].
Increased lactate levels on ICU were linked to adverse outcomes in general populations of
critically ill patients [13–15] and in patients after cardiac surgery [16–19]. In contrast, the
influence of base excess and other metabolic indices on ICU mortality remains currently elu-
sive [20–23]. Nevertheless, base excess was shown a strong predictor for mortality in specific
subsets of ICU patients such as e.g. major trauma and in patients with cardiogenic shock [24,
25]. However, whether the BD typically seen after cardiac surgery is actually related to the ele-
vated lactate levels is currently controversially discussed [10, 26, 27]. The paucity of data and
the controversial discussion on the role of BE on mortality in cardiosurgical patients leads to
uncertainty regarding its value as a prognostic tool [11, 28]. We therefore embarked to investi-
gate the prognostic importance of lactate- and BE- levels on ICU mortality after cardiac sur-
gery. Furthermore, we aimed to define lactate- and BE-cut-off values in respect to mortality
prediction and to investigate the prognostic role of combinations of metabolic indices in
respective critically ill patients.
Materials and methods
Setting
Patient data from a 14-bed cardiac surgery ICU of the department of intensive care medicine,
University Medical Center Hamburg-Eppendorf during the recording period (February 2009
–March 2010) were analyzed in a retrospective fashion.
Inclusion/Exclusion criteria
All adult patients (18 years) treated at our facility within the study period were eligible for
inclusion. Exclusion criteria were as follows: Patients after off-pump surgery, patients who
underwent heart-/ and/or lung- transplantation, patients on extracorporeal assist devices, and
patients with incomplete data sets.
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Ethical considerations
Ethical approval and informed consent for data analysis and publication of this retrospective,
observational, non-interventional investigation using anonymized chart data was not required
(Research Ethics Committee of the Hamburg Chamber of Physicians). The analysis was per-
formed in adherence to the Declaration of Helsinki.
Conduct of the analysis
Preoperative data, EUROscore (European System for Cardiac Operative Risk Evaluation), and
preoperative comorbidities such as renal impairment (defined as serum creatinine >200μmol/
L), chronic obstructive pulmonary disease (COPD), pulmonary hypertension (PHT, defined
as systolic pulmonary artery pressure >60mmHg), severely reduced left ventricular ejection
fraction (LVEF, defined as LVEF<35%), re-operation, and emergency operation were
recorded.
Standardized treatment was applied for cardio-anesthesia, cardiopulmonary bypass con-
duction/weaning, and perioperative care in all patients. Standards for conduct of anesthesia,
operative procedures, ECC-protocol (pump-flow 2.5l/min/m2 body surface, mean arterial
pressure 65-50mmHg, mild hypothermia (31–32˚C), transfusion trigger: hematocrit <22%)
including pump-prime volume, and postoperative care for these patients were unchanged dur-
ing the study period. Routine point of care blood gas analyses directly after ICU admission
were performed from blood samples drawn from arterial catheters inserted in the radial or
femoral arteries (Radiometer Copenhagen; ABL 700 Series, Willich, Germany).
Patients extubation criteria were fulfilled when patients were stable on moderate pressure
support and PEEP while having a paO2>60mmHg and FiO2<0.4 as well as the ability to suffi-
ciently protect their airway and follow commands. Patients were discharged from the ICU in
case of hemodynamic stabilization without vasoactive medication, stable respiratory condi-
tions, and neurologically adequate.
Complications on the ICU were defined as: surgical revision with/without CPB, cardiopul-
monary resuscitation, postoperative coronary angiography for suspected cardiac ischemia, sec-
ondary cardiac failure, postoperative respiratory failure (re-intubation, non-invasive
ventilation), postoperative infectious complication, delirium, multiple organ failure, acute kid-
ney injury with need for continuous renal replacement therapy (CRRT) and/or others. More-
over, requirement of transfusion of blood products (red packed blood cells, fresh frozen
plasma, and/or platelets) within the early postoperative phase (first 12 hours) were noted.
Statistical analysis
Statistical analysis was performed with MedCalc 17.4 (MedCalc Software, Ostend, Belgium).
Normal distribution was tested using the Kolmogorov-Smirnov test. Continuous variables are
presented as median and interquartile ranges (IQR). For categorical variables, numbers and
proportions are reported, where appropriate.
For lactate- and BE-levels at ICU admission, receiver operating characteristic (ROC) curves
and respective areas under the ROC curves (AUC) were constructed. Optimal cut-off values
for lactate- and BE-levels were calculated based von ROC-construction and highest sensitivity/
specificity to evaluate the diagnostic ability of the respective acid-base parameters. Optimal
cut-off levels for lactate and BE were chosen under estimation of an equivalent weighting of
sensitivity (Se) and specificity (Sp) according to the following formula: J = maxc [Se (c) + Sp (c)
– 1] (c: cut off-point). Youden´s index was used to define the maximum potential efficiency of
lactate- and BE-levels.
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Univariate regression analysis followed by multivariate regression were performed to
explore the relationship between metabolic parameters and ICU mortality.
A sensitivity analysis including combinations of lactate and BE cut-off values in respect to
ICU mortality was performed by Cox proportional hazards regression models. Comparison of
lactate-levels in survivors and non-survivors were performed using Chi-square testing. A two-
tailed p<0.05 was considered statistical significant.
Results
Patient demographics
Out of 1,292 patients, 1,058 were included in this analysis. The CONSORT flowchart is given
in Fig 1. Demographic data are given in Table 1. The median age of the patient population was
69.8 (interquartile range, IQR, 61.1 75.5) with a male predominance (n = 715, 67.6%). General
preoperative health status showed a median EUROscore of 4 (IQR 2 6) with less than 10% of
all patients suffering from chronic obstructive pulmonary disease (COPD), renal impairment,
pulmonary artery hypertension, or severely reduced left ventricular function (Table 1). Sev-
enty-five of all patients (7.1%) underwent an emergency operation. The median duration of
cardiopulmonary bypass (CPB)-time was 129 minutes (IQR 103–167 minutes), aortic cross
clamp (AOX)–time was 84 minutes (IQR 63–109.8 minutes). At postoperative ICU-admission,
median lactate-levels were 1.6mmol/l (IQR 1.0–2.5mmol/l), base excess was -2.5 (IQR -4 to
Fig 1. Study flow chart. HTX: heart transplantation, LTX: lung transplantation, ECMO: extracorporeal membrane oxygenation, VAD:
ventricular assist device.
https://doi.org/10.1371/journal.pone.0205309.g001
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-1.2), respectively. The median duration of mechanical ventilation was 8.7 hours (IQR 5.8–
13.0 hours). Twenty-one patients (2%) died on the ICU. In survivors, median lactate-levels
were 1.5mmol/l (IQR 1.0–2.4mmol/l), respectively 4.9mmol/l (IQR 4.9–8.9mmol/l) in non-
survivors (p = 0.0001). Median base excess was -2.5 (IQR -4 to -1.2) in survivors, and -6.7 (ICR
-8.08 to -2.64, p = 0.0007) in non-survivors, respectively.
Sensitivity and specificity analysis
Receiver operating curves (ROC) for lactate-level and BE at ICU admission were computed in
respect to ICU mortality (Fig 2). Pairwise comparison of ROC curves revealed no statistical
differences of ROC curves of lactate-level and BE (p = 0.27). The optimal lactate cut-off value
to predict ICU mortality was >3.9mmol/l (sensitivity 61.9, specificity 87.5%, Youden´s Index
0.49). For BE the optimal cut-off value to predict ICU mortality was -6.7 with a sensitivity of
52.4% and a specificity of 93.8%, (Youden´s index 0.46).
Correlation analysis of lactate levels at ICU admission
Lactate-levels at ICU admission were positively correlated with CPB-time (r = 0.44, p<0.0001,
95%-CI 0.39–0.49), AOX-time (r = 0.32, p<0.0001, 95%-CI 0.27–0.38), and EUROscore
(r = 0.27, p<0.0001, 95%-CI 0.21–0.33). A negative correlation was observed for BE (r = -0.48,
p<0.0001, 95%-CI -0.52 to -0.43).
Table 1. Patient demographics and perioperative data.
all patients
(n = 1058)
Pre-operative data
Female gender (%) 343 (32.4)
Age (years) 69.8 (61.1–75.5)
EuroSCORE, 4 (2 to 6)
COPD (%) 85 (8.0)
Renal impairment (%) 64 (6.0)
PHT (%) 30 (2.8)
LVEF <35% (%) 76 (7.2)
Re-operation (%) 40 (3.8)
Emergency operation (%) 75 (7.1)
Intra-operative data
CPB-Time (min) 129 (103–167)
AOX-Time (min) 84 (63–109.75)
Outcome data
Length of stay on ICU (days) 2 (2 to 3)
Mechanical ventilation on ICU (hours) 8.7 (5.83–13.0)
Transfusion of blood products on ICU, any type (%) 653 (61.72)
Complications on ICU, any type (%) 99 (9.36)
ICU-mortality (%) 21 (1.98)
Data are presented as median and interquartile ranges, or absolute frequencies. ICU: intensive care unit ICU:
intensive care unit; EUROscore: European System for Cardiac Operative Risk Evaluation; COPD: chronic obstructive
pulmonary disease; PHT: pulmonary hypertension; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary
bypass; AOX: aortic cross clamp.
https://doi.org/10.1371/journal.pone.0205309.t001
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Correlation analysis of base excess at ICU admission
Negative correlation was found for CPB-time (r = -0.12, p = 0.0007, 95%-CI -0.17 to -0.05),
AOX-time (r = -0.07, p = 0.03, 95%-CI -0.13 to -0.01), and EUROscore (r = -0.2, p<0.0001,
95%-CI -0.26 to -0.14).
Univariate and multivariate regression analysis
In univariate regression analysis, EUROscore, CPB-time, pre-existing severe reduced LVEF,
re-operation, postoperative complications, lactate-level and BE (continuous values) at ICU
admission were related to ICU-mortality (all p<0.05, see Table 2). Furthermore, the lactate-
level at ICU admission above the optimal differentiating cut-off value (p = 0.01) and BE
(p = 0.0001) below the optimal cut-off value at ICU admission was associated with ICU-mor-
tality. In multivariate Cox regression analysis, BE -6.7 was revealed as the only independent
predictor of ICU-mortality (Hazard ratio 4.78, 95%-CI 1.4–16.33, p = 0.01; overall model
fitness Chi2 18.67, p = 0.002). Data on uni- and multivariate analysis are given in Table 2.
Despite associations of postoperative complications (any type) with mortality in univariate
regression models, inclusion in the multivariate model was rejected in an effort to investigate
early potential metabolic indices (at admission) as early predictors. However, in alternative
multivariate regression models including postoperative complications (any type) independent
predictors of ICU-mortality were CPB-time (HR 1.01, 95%-CI 1.0–1.01, p = 0.04),
Fig 2. Comparison of receiving operating curves (ROC) for prediction ICU-mortality. Comparison of receiving
operating curves (ROC) for prediction of ICU-mortality. Lactate AUROC = 0.79 (95%-CI 0.77–0.82); base excess
AUROC = 0.72 (95%-CI 0.69–0.74), p = 0.27.
https://doi.org/10.1371/journal.pone.0205309.g002
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postoperative complications (HR 8.12, 95%-CI 2.83–23.28, p = 0.0001), and BE -6.7 at ICU
admission (HR 4.41, 95%-CI 1.39–14.03, p = 0.01; overall model fitness Chi2 34.44, p<0.0001).
Sensitivity analysis for different combinations of lactate-levels and base
excess cut-off values
For further analysis of ICU mortality, patients were divided into four subgroups with respect
to their cut-off values for lactate- and BE-levels at ICU admission. A scatterplot of these sub-
groups is given in Fig 3). The mortality rate for the first subgroup (lactate3.9mmol/l and BE
> -6.7) was 0.79% (n = 7/880), for second subgroup (lactate3.9mmol/l and BE -6.7) 3.7%
(n = 1/27), for third subgroup (lactate >3.9mmol/l and BE > -6.7) 3.12% (n = 3/93) and for
the fourth subgroup (lactate >3.9mmol/l and BE -6.7) 21.28% (n = 10/37). Respective haz-
ard ratios and 95%-confidence intervals of the different subgroups are indicated (see Table 3).
Discussion
The aim of this analysis was to investigate the relevance of key metabolic indices with regard to
prediction of ICU mortality in patients undergoing on-pump cardiac surgery admitted to a
tertiary care ICU. Our data show that BE below -6.7 at ICU admission is the only predictor for
ICU mortality in a large cohort of mixed cardiosurgical patients.
Base excess as a potential indicator of mortality in post-cardiosurgical patients was scarcely
investigated thus far. Few previous studies are limited by lack to assess postoperative mortality
Table 2. Univariate and multivariate Cox proportional hazard regression models for patients variables.
Variables Univariate model for ICU mortality Multivariate model for ICU mortality
Hazard ratio (95% CI) P value Wald Hazard ratio (95% CI) P value Wald
Preoperative data
Gender (female) 0.8 (0.31–2.08) 0.64 0.22 - - -
Age (per 1 year increase) 1 (0.95–1.03) 0.58 0.3 - - -
EUROscore, additive (per 1 step increase) 1.19 (1.05–1.35) 0.006 7.65 - - -
COPD (y/n) 1.03 (0.24–4.47) 0.97 0.001 - - -
Renal impairment (y/n) 0.45 (0.06–3.34) 0.43 0.62 - - -
PHT (y/n) 2.86 (0.65–12.51) 0.16 1.94 - - -
LVEF <35% (y/n) 3.66 (1.37–9.78) 0.01 6.7 2.23 (0.75–6.71) 0.15 2.08
Re-operation (y/n) 3.67 (1.19–11.3) 0.02 5.15 3.39 (0.89–12.91) 0.07 3.19
Emergency operation (y/n) 1.47 (0.43–5.03) 0.55 0.37 - - -
Intraoperative data
CPB-Time (per 1 minute increase) 1.01 (1–1.01) 0.01 7.63 1 (1–1.01) 0.08 3.05
AOX-Time (per 1 minute increase) 1 (1–1.01) 0.09 2.86 - - -
Parameters at ICU admission
Lactate (per 1mmol/l increase) 1.16 (1.07–1.26) 0.0003 13.28 - - -
Base excess (per one unit increase) 0.83 (0.73–0.93) 0.002 9.36 - - -
Lactate >3.9mmol/l (y/n) 3.48 (1.33–9.13) 0.01 6.44 0.87 (0.25–3.08) 0.83 0.04
Base excess - 6.7 (y/n) 6.37 (2.5–16.21) 0.0001 15.07 4.78 (1.4–16.33) 0.01 6.22
Postoperative data
Mechanical ventilation on ICU (per hours increase) 1 (1–1) 0.87 0.03 - - -
Postoperative complications (any type, y/n) 8.74 (3.15–24.27) <0.001 17.32 - - -
Enter Cox-proportional hazards regression. ICU: intensive care unit; EUROscore: European System for Cardiac Operative Risk Evaluation; COPD: chronic obstructive
pulmonary disease; PHT: pulmonary hypertension; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary bypass; AOX: aortic cross clamp
https://doi.org/10.1371/journal.pone.0205309.t002
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[28] or by the fact that multivariate analyses including relevant confounding factors were not
performed [11, 17, 28, 29]. In our analysis, we focused on early potential metabolic indices to
predict ICU-mortality. We found that severely negative base excess at postoperative ICU
admission after cardiosurgery was the only predictor for ICU mortality. This seems important
from a clinical perspective and may be relevant for clinicians in efforts for early identification
of post-cardiosurgical patients at highest risk. Moreover, in the further course of the ICU-stay,
complications increased the risk of ICU-mortality noticeably in addition to severely reduced
BE at ICU admission.
In contrast to factors associated with increased lactate levels after cardiac surgery that were
extensively studied and mostly reflect circulatory shock states [26, 30, 31], the underlying fac-
tors for the systemic reduced BE in patients after cardiac surgery remain less clear. One study
linked reduced BE to occult tissue hypo-perfusion [32]. Two further studies in patients with
trauma and cardiogenic shock revealed an associated with mortality, but without clear expla-
nations on the underlying pathomechanisms [24, 25]. However, it should be taken into
account that decreased BE, as increased lactate, has potential confounders and may be related
to multiple etiological factors.
Whether BE or lactate level has better prognostic abilities is controversially discussed so far.
Two studies in trauma patients showed that BE is a superior predictor for mortality when
Fig 3. Scatterplot of lactate and base excess levels at admission on ICU after cardiac surgery. 1st group: Lactate3.9mmol/l and BE>
-6.7 (n = 887): r = -0.1, p = 0.002, 95%-CI -0.17 to –0.04 2nd group: Lactate3.9mmol/l and BE -6.7 (n = 28): r = -0.06, p = 0.78, 95%-
CI -0.42 to 0.32 3rd group: Lactate>3.9mmol/l and BE> -6.7 (n = 96): r = -0.06, p = 0.58, 95%-CI -0.27 to 0.15. 4th group: Lactate
>3.9mmol/l and BE -6.7 (n = 47): r = -0.36, p = -0.01, 95%-CI -0.59 to -0.08 Overall correlation (n = 1058): r = -0.48, p<0.0001, 95%-CI
-0.52 to -0.43.
https://doi.org/10.1371/journal.pone.0205309.g003
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compared to lactate [33, 34], while another study in a mixed-surgical ICU cohort showed no
difference in mortality predicting properties between lactate and BE [22]. However, multivari-
ate analyses were not performed in these studies.
Only a few studies investigated the relationship between lactate and base excess levels at
ICU admission in respect to ICU mortality. In our analysis, the highest mortality was found in
the subgroup with hyperlactatemia and severe reductions in base excess (group 4). This
appeared not surprising as this constellation may reflect severe lactic acidosis, which was
related to a particular high ICU mortality previously [20, 31, 35] and could be related to severe
shock states [26, 30, 31]. The second subgroup with a severely reduced BE without concurrent
hyperlactatemia has a particular high mortality ratio also. This may point to independent mor-
tality-associated effects of BE.
A common approach for interpretation of biomarkers, especially metabolic indices such as
lactate-and BE-levels, is to use the normal ranges provided by hospital laboratories as cut-off
values to predict adverse clinical outcomes. However, the utility of these cut-off values for
prognostication may highly depend on the sensitivity and specificity of the population in
which the biomarker was tested. This is also reflected by significantly different prognostic abil-
ities of lactate levels in trials where an a priori laboratory lactate cut-off level of 2mmol/l was
used [35–37] when compared to studies where population specific cut-off values were calcu-
lated [29]. Our analysis points to the fact that the ideal population based cut-off for lactate for
mortality prognostication after cardiac surgery is about 4mmol/l [29]. It was also shown that
specificity increased if the cut-off was raised to 5mmol/l but a significant loss of sensitivity
must be noted [17]. However, the ideal lactate cut-off for mortality prediction after cardiac
surgery is still a matter of on-going debate.
Our analysis has limitations that deserve discussion. First, our study is limited by the rela-
tively small sample size with limited event rates (limited event rates may be considered typical
in the specific cohort under investigation). Further, due to the single center design our results
may have limited external validity. Moreover, data on long-term follow-up was not available
Table 3. Hazard ratios with 95% confidence intervals and medians for combinations of lactate and base excess.
1st group
Lactate <3.9mmol and
BE > -6.7
2nd group
Lactate <3.9mmol/
and
BE -6.7
3rd group
Lactate >3.9mmol/l
and
BE > -6.7
4th group
Lactate >3.9mmol/l
and
BE -6.7
Hazard ratios with 95% confidence interval
1st group
Lactate <3.9mmol and
BE > -6.7
- 2.97 (0.23–39.07) 1.16 (0.4–3.36) 5.76 (1.67–19.94)
2nd group
Lactate <3.9mmol/
and
BE -6.7
0.34 (0.02–4.43) - 0.39 (0.03–5.67) 1.94 (0.12–30.42)
3rd group
Lactate >3.9mmol/l
and
BE > -6.7
0.86 (0.3–2.49) 2.56 (0.18–37.17) - 4.98 (1.19–20.87)
4th group
Lactate >3.9mmol/l
and
BE -6.7
0.17 (0.05–0.6) 0.52 (0.03–8.05 0.2 (0.05–0.84) -
Data for subgroups of lactate and BE cut-off values at admission on ICU
https://doi.org/10.1371/journal.pone.0205309.t003
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preventing further analyses on mid-and long-term clinical outcomes. Second, and most
importantly, we report associations rather than causal relationships. Thus, the underlying rea-
sons for base excess and/or lactate changes remain unclear. Further, we were unable to evalu-
ate patients in regard to liver dysfunction, which could be a reason for increased systemic
lactate levels in some patients. Due to the retrospective fashion of this analysis, preoperative
baseline characteristics of BE and lactate-levels were not available. Last, neither chloride-levels
nor fluid intake, which both impact on the metabolic status of respective patients [8, 15, 23,
38], were recorded, therefore a hyperchloraemic acidosis and/or dilutional acidosis in respec-
tive patients cannot be excluded with certainty.
Conclusions
In a large cohort of post-cardiosurgical patients, we observed that severely reduced base excess
at ICU admission is superior to lactate levels for prediction of ICU-mortality. Diminished base
excess was the only single independent predictor for ICU mortality after correction for typical
confounders, including hyperlactatemia. Subgroup analyses investigating different BE and lac-
tate cut-off levels point towards BE as a key player in respect to mortality prediction in this
clinical scenario. Hence, lactate levels interpreted alone as a biomarker provides limited prog-
nostic- and risk-stratification value. Thus, we advocate assessment of admission metabolic
conditions after cardiac surgery in an effort to optimize risk stratification in the very early
phase of postoperative care on the ICU.
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